ArticleCardiovascular drugs and therapy2025

Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting System.

Bo Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.